Evaxion Biotech AS

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$37
$122
$122
$3,026
Gross Profit
37
122
3,026
EBITDA
-4,785
-1,375
-1,647
EBIT
-1,736
Net Income
-4,831
-1,580
-3,629
-1,941
Net Change In Cash
37
122
122
3,026
Cash
14,746
17,843
5,052
4,576
Basic Shares
4,831
1,105
70,130
1,381

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$3,344
$73
$0
$0
Gross Profit
3,344
72
-571
-343
EBITDA
-9,769
-21,403
-22,584
-24,168
EBIT
-10,376
-22,018
-23,155
-24,511
Net Income
-10,567
-22,125
-23,169
-24,532
Net Change In Cash
3,344
73
0
0
Free Cash Flow
-12,940
-17,778
-26,066
-23,293
Cash
5,052
5,583
13,184
32,166
Basic Shares
1,072
683
590
487

Earnings Calls

Quarter EPS
2025-06-30
-$1
2025-03-31
-$3.14
2024-12-31
-$0.07
2024-09-30
-$0.04